Low-dose lipopolysaccharide as an immune regulator for homeostasis maintenance in the central nervous system through transformation to neuroprotective microgliaOACSCD
Low-dose lipopolysaccharide as an immune regulator for homeostasis maintenance in the central nervous system through transformation to neuroprotective microglia
Haruka Mizobuchi;Gen-Ichiro Soma
Control of Innate Immunity,Technology Research Association,Kagawa,JapanControl of Innate Immunity,Technology Research Association,Kagawa,Japan
cognitive impairmentendotoxinlipopolysaccharidelow-dosemicroglianeuroprotectionoral administrationpreconditioningtolerancetrained innate immunity
cognitive impairmentendotoxinlipopolysaccharidelow-dosemicroglianeuroprotectionoral administrationpreconditioningtolerancetrained innate immunity
《中国神经再生研究(英文版)》 2021 (10)
1928-1934,7
This work was funded by Control of Innate Immunity Technology Research Associationa grant of Cross-ministerial Strategic Innovation Promotion Program, SIP-No. 14533073 (to GIS) from the Council for Science from Technology and Innovation (CSTI) in Cabinet Office of Japanese Government and the National Agriculture and Food Research Organization (NARO).